\n
\r\n<\/a>\r\n<\/p>\n<\/div><\/section><\/div>
\r\n\r\n
<\/a>\r\n<\/div><\/p>\n<\/div><\/section>
\nSartorius partners with SPARTA Biodiscovery to facilitate launch of novel nanoparticle analysis platform<\/h1>E-News<\/a> <\/span><\/span><\/header>\n<\/div><\/section>

\n
Sartorius partners with SPARTA Biodiscovery to facilitate launch of novel nanoparticle analysis platform<\/h1>E-News<\/a> <\/span><\/span><\/header>\n<\/div><\/section>
\nThe life science group Sartorius and UK-based start-up SPARTA Biodiscovery have agreed to partner on SPARTA\u2019s analysis platform, which helps speed up the development, manufacture, and quality control of nanoparticles for bio-pharmaceutical drugs.<\/h3>\n<\/p>\n
Nanoparticles are small polymer or lipid capsules that act as carriers to deliver active agents to the target cells. As part of the cooperation, Sartorius will invest up to \u00a33.5 million in a minority share-holding in SPARTA Biodiscovery through its corporate investment unit Sartorius Ventures.<\/p>\n<\/div><\/section>
\n
The life science group Sartorius and UK-based start-up SPARTA Biodiscovery have agreed to partner on SPARTA\u2019s analysis platform, which helps speed up the development, manufacture, and quality control of nanoparticles for bio-pharmaceutical drugs.<\/h3>\n<\/p>\n
Nanoparticles are small polymer or lipid capsules that act as carriers to deliver active agents to the target cells. As part of the cooperation, Sartorius will invest up to \u00a33.5 million in a minority share-holding in SPARTA Biodiscovery through its corporate investment unit Sartorius Ventures.<\/p>\n<\/div><\/section>
\n
\n